Novo Nordisk
NVO
#78
Rank
โ‚ฌ185.72 B
Marketcap
41,77ย โ‚ฌ
Share price
1.31%
Change (1 day)
-42.84%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) Fails to deliver data

Key failure to deliver metrics for Novo Nordisk:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novo Nordisk (NVO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013

Volume in USD (price x number of shares), data since 2013

Novo Nordisk (NVO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ20.9 M-94.28%
2025โ‚ฌ0.36 B47.59%
2024โ‚ฌ0.24 B179.42%
2023โ‚ฌ88.71 M-11.66%
2022โ‚ฌ0.10 B125.23%
2021โ‚ฌ44.58 M70.14%
2020โ‚ฌ26.2 M-57.24%
2019โ‚ฌ61.28 M-22.47%
2018โ‚ฌ79.04 M3.14%
2017โ‚ฌ76.63 M5.66%
2016โ‚ฌ72.53 M-28.24%
2015โ‚ฌ0.10 B-51.63%
2014โ‚ฌ0.20 B598.64%
2013โ‚ฌ29.9 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
โ‚ฌ56.21 Mโ‚ฌ0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ0.20 Bโ‚ฌ0.41 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ10.89 Mโ‚ฌ69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ31.05 Mโ‚ฌ81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA